IASIC Speaker Series Presents Marijuana Biology: Does Potency Matter?

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed, organized, and guided by doctors.

Presented By: Bertha Madras, PhD
Date:Thursday, January 6, 2022
Time: 4:00PM Eastern/1:00PM Pacific
Price: FREE

The endocannabinoid system in the body is a primary target of THC, the key cannabinoid in marijuana. What is the endocannabinoid signaling system? Where is it localized? What are its functions? How do THC and endocannabinoids act? What are phytocannabinoids (compounds made by plants)? What are THC actions in the body? (receptor targets in the brain, peripheral tissues) Do THC and opioid signaling systems crosstalk? Do actions by THC (plant-derived) or endocannabinoids (made by the brain) differ? Does THC affect neurodevelopment? Medical marijuana and recreational marijuana; do they differ? What are the consequences of THC actions? Does THC engender neuroadaptive changes? Are the effects of THC related to dose and frequency of use? What are the short- and long-term implications of marijuana?

Weekly sessions in the IASIC Speaker Series are free to join and the schedule is constantly expanding! For more information visit 
www.IASICeducation.org.

Register for this FREE Session
View Upcoming Speakers

For more information on the International Academy on the Science and Impact of Cannabis, and to join, please visit www.IASIC1.org.

Visit the IASIC Library here. The IASIC Library is intended as a user-friendly reference of the published medical literature.

Like this article?

Share on facebook
Share on Facebook
Share on twitter
Share on Twitter
Share on linkedin
Share on Linkdin
Share on pinterest
Share on Pinterest

Leave a comment

Related Posts

Sentinel Surveillance of Substance-Related Poisonings in Canada: Spotlight on Cannabis

Substance-related poisonings and injuries in Canada have received increasing attention in recent years due to emerging public health concerns, such as the opioid overdose crisis, the introduction of synthetic cannabinoids to the illicit market and the emergence of electronic cigarettes/vaping products on the Canadian market. Furthermore, there has been a general increase in substance-related hospitalizations

Changes in Rates of Hospitalizations due to Cannabis Harms in Ontario, Canada Before the Legalization of Nonmedical Cannabis: Retrospective Population-level Study Between 2003 and 2017

There are distinct patterns of hospitalizations due to cannabis harms in different priority populations. Young women aged 15 to 24 are a key demographic that is disproportionately burdened with a rapid increase in hospitalizations due to cannabis harms. Jurisdictions considering new approaches to cannabis control policy and addiction services should consider the rising burden of

Cannabis and Psychosis: Recent Epidemiological Findings Continuing the “Causality Debate”

Nonmedical (“recreational”) cannabis use and cannabis laws have changed over the past two decades in the United States (1) and the rest of the world (2). Increasing use, especially among the young, coupled with the increasing potency of cannabis (higher delta-9-tetrahydrocannabinol [THC] content) during this period (3), has raised concerns about the long-term health impact

Scroll to Top